Viagra Cost vs. Alternatives: Comparing Sildenafil to Every PDE5 Inhibitor in Class

Sildenafil is the generic name for the active ingredient in Viagra (Pfizer's brand) and in Revatio, a lower-dose version of the same molecule approved for pulmonary arterial hypertension. Tadalafil (brand Cialis), vardenafil (brand Levitra), and avanafil (brand Stendra) are the other three oral phosphodiesterase type 5 (PDE5) inhibitors approved by the FDA for erectile dysfunction (ED). All four are prescription-only.

Generic sildenafil is, as of this writing, the least expensive PDE5 inhibitor available in the United States, and pharmacy prices for the drug class change often enough that any specific dollar figure should be treated as a snapshot rather than a fixed rate. Generic tadalafil is the closest competitor on price and has features (a longer window of action, an FDA-approved daily dosing option, and a dual indication for benign prostatic hyperplasia) that can make it the better clinical fit even when it costs slightly more per dose. Vardenafil and avanafil generally cost more than either, without a body of evidence showing they work better for typical patients.

What is established, what is plausible, and what is not established

Established: All four PDE5 inhibitors work through the same mechanism, are FDA-approved for ED, and are described by regulators and specialty guidelines as producing broadly comparable improvements in erectile function for most men. Generic sildenafil and generic tadalafil are the two most price-competitive options because both compounds lost patent exclusivity years ago, which opened the market to multiple manufacturers.

Plausible but not rigorously quantified on this page: Claims that one drug produces a specific percentage-point advantage over another in head-to-head trials appear throughout the marketing and secondary literature. Some of those numbers are real, some are attached to the wrong study, and none should be repeated here as a precise clinical benchmark without checking the original trial report. Where this article references trial findings, it describes direction and rough magnitude rather than presenting numbers as verified facts.

Not established: That a higher price predicts better outcomes anywhere in this drug class. No guideline body reviewed for this article recommends a costlier PDE5 inhibitor as first-line therapy on efficacy grounds alone.

How PDE5 inhibitors work, and why price varies so much within one mechanism

During sexual arousal, nitric oxide triggers the smooth muscle of the penis to produce cyclic GMP (cGMP), which relaxes blood vessels and allows the corpus cavernosum to fill with blood. The enzyme PDE5 breaks cGMP down. Sildenafil, tadalafil, vardenafil, and avanafil all block PDE5, which lets cGMP accumulate and helps sustain an erection during arousal. This is textbook pharmacology, not a matter of dispute between the four drugs; the differences between them are in selectivity, half-life, and how much off-target enzyme (such as PDE6 in the retina or PDE11 in skeletal muscle) each drug also inhibits.

Because the mechanism is shared, price differences within the class track patent history and market competition more than pharmacology. Sildenafil and tadalafil both lost U.S. patent protection years ago and now have multiple generic manufacturers, which is the standard driver of lower generic prices under the generic drug approval process regulators use to establish therapeutic equivalence. Vardenafil has fewer generic manufacturers, and avanafil, the newest entrant (FDA-approved in 2012), still has limited generic competition. Fewer manufacturers generally means less downward price pressure.

What sildenafil, tadalafil, vardenafil, and avanafil typically cost

Retail cash prices for generic prescription drugs vary by pharmacy, region, quantity, and discount program, and they change over time, so treat the ranges below as a general orientation rather than a quote you can rely on for budgeting. Verify current pricing at your own pharmacy or through a discount-card tool before assuming any of these figures still holds.

• Generic sildenafil tablets are widely reported as the cheapest option in the class, often available for well under a few dollars per tablet through discount pharmacy programs, with brand-name Viagra priced dramatically higher for the same molecule.
• Generic tadalafil tablets are usually the second-cheapest option and can approach sildenafil's price floor at some pharmacies.
• Generic vardenafil tablets typically cost several times more than generic sildenafil or tadalafil for a comparable dose.
• Avanafil (Stendra) has limited generic competition and is usually the most expensive drug in the class per tablet.

Medicare Part D has historically excluded erectile dysfunction drugs from coverage as a matter of statute; readers with Medicare should confirm current coverage rules directly with their plan rather than assume this article's summary is still accurate, since coverage policy can change (H.R. 1, 108th Congress, Medicare Prescription Drug, Improvement, and Modernization Act of 2003). Commercial insurance plans commonly apply monthly quantity limits (often in the range of 6 to 12 tablets) rather than excluding ED drugs outright, but plan design varies and should be checked with the specific insurer.

If you buy medication online to save money, verify that the pharmacy is licensed and requires a valid prescription; regulators have published general consumer guidance on identifying safe online pharmacies and avoiding counterfeit medication.

Tadalafil: the closest competitor on price, with real trade-offs

Tadalafil has a substantially longer half-life than sildenafil, which is well-established pharmacology and is reflected in its labeled dosing: tadalafil is the only PDE5 inhibitor FDA-approved for daily dosing (commonly 2.5 mg or 5 mg) as well as on-demand use, while sildenafil is approved only for on-demand dosing before sexual activity. The longer window of action (commonly cited as up to roughly a day and a half) means timing a dose around sex matters less than it does with sildenafil, whose effect window is a few hours.

Tadalafil also carries an FDA-approved indication for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH) at the 5 mg daily dose, which sildenafil does not have. For a man being treated for both ED and BPH, one tadalafil prescription can address both conditions, which may reduce total medication cost even if the per-tablet price is not the lowest in the class.

The trade-off reported in the literature is a higher rate of musculoskeletal side effects (back pain and myalgia) with tadalafil compared with sildenafil, plausibly related to tadalafil's greater cross-reactivity with PDE11 found in skeletal muscle. The exact incidence figures vary by study and should be checked against tadalafil's current FDA label rather than any secondary summary, including this one.

Vardenafil and avanafil: comparable efficacy, higher cost, narrower use case

Vardenafil's onset, duration, and PDE5 selectivity are similar to sildenafil's. Specialty guidance and systematic reviews of the PDE5 inhibitor class have generally not found a clinically meaningful efficacy advantage for vardenafil over sildenafil, while vardenafil usually costs more. Its main differentiator is an orally disintegrating tablet formulation that does not require water, which may matter for some patients but is not an efficacy advantage.

Avanafil is marketed on speed: trial data described in the avanafil labeling and clinical literature support a faster onset than the other three drugs, with some men achieving an erection sufficient for intercourse within roughly 15 minutes of dosing in controlled studies. Avanafil is also reported to have the highest PDE5 selectivity of any drug in the class, which is the proposed explanation for a lower rate of the visual disturbances (transient blue-tinged vision) that sildenafil can cause through off-target PDE6 inhibition in the retina. For most men, faster onset alone does not justify avanafil's substantially higher price. Its practical niche is men who need rapid onset or who cannot tolerate sildenafil's visual side effect and are willing to pay for that.

Do you get more efficacy for a higher price? The honest answer is no

The American Urological Association's guideline on erectile dysfunction takes the position that PDE5 inhibitors as a class are comparably effective, and that the choice between them should be guided by side-effect profile, pharmacokinetics, cost, and patient preference rather than an expectation of superior efficacy from any one agent (AUA, Erectile Dysfunction guideline). That guideline position, not a marketing claim from any manufacturer, is the most authoritative statement available on this question, and it is the reason this article treats price as the main variable once a drug is medically appropriate for a given patient.

This does not mean the four drugs are interchangeable for every patient. Half-life, selectivity, and approved dosing schedules differ in ways that matter clinically even when average efficacy is similar across trials, which is why the sections above and the table below separate "cheapest" from "best fit."

A decision framework: which PDE5 inhibitor fits which situation

Practical ways to lower the cost of any PDE5 inhibitor

• Pill splitting sildenafil. A 100 mg tablet often costs close to the same as a 50 mg tablet at the same pharmacy. Splitting a 100 mg tablet with a proper pill cutter can approximate two 50 mg doses at roughly half the per-dose price, a practice many prescribers are comfortable with, though the exact split dose is not guaranteed to be even and should be discussed with the prescribing clinician rather than self-directed for the first time.
• Sildenafil 20 mg (Revatio-strength) tablets used off-label for ED. This is an off-label use of a different FDA-approved indication (pulmonary arterial hypertension), not an FDA-approved ED regimen, and dosing should be set by a prescriber, not assembled independently from pill counts.
• Discount cards and cost-plus pharmacy models. These can bring generic sildenafil or tadalafil below a typical commercial copay, but availability and pricing change and should be checked at the time of purchase.
• Manufacturer savings programs for branded drugs like Stendra. These typically apply only to commercially insured patients and not to government insurance programs; check current terms before assuming a specific discount applies.

None of these strategies substitute for confirming with a prescriber that the chosen drug, dose, and any dose-splitting plan are appropriate for your cardiovascular history, current medications, and kidney or liver function.

When to seek care rather than compare prices

Sudden loss of vision or hearing after taking any PDE5 inhibitor, an erection lasting more than four hours (priapism), or chest pain during sexual activity are reasons to seek urgent medical care rather than troubleshoot which drug is cheaper. New or worsening erectile dysfunction can also be an early marker of cardiovascular disease, so a first ED diagnosis in a man without a recent physical is a reasonable prompt for a broader cardiovascular check, not only a prescription decision.

The bottom line

Generic sildenafil is usually the cheapest starting point in the PDE5 inhibitor class, and no guideline reviewed here supports paying more for a different drug in this class on efficacy grounds alone. Generic tadalafil is the main exception worth considering even at a slightly higher price, because its daily dosing option and BPH indication solve problems that price alone does not. Vardenafil and avanafil are reasonable choices for a narrower group of patients (formulation preference, or a documented need for very fast onset) but are not supported as superior for the average patient. Any contraindication, especially concurrent nitrate use, overrides all of the above and should be resolved with a prescriber before cost enters the conversation.